Abstract
An informed consent article using
Hammond FM, Alexander DN, Cutler AJ, et al. PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology. 2016;16:89. https://doi.org/10.1186/s12883-016-0609-0
for a patient with pseudobulbar affect following stroke
DOI
10.22237/crp/1636070400
Creative Commons License
This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License
Recommended Citation
FRANCIS M, HAMAME M, NASRALLAH M, NESBITT A, MEZA JP. Informed Consent: Dextromethorphan-quinidine is helpful for pseudobulbar affect disorder in stroke patients. Clin. Res. Prac. Nov 5 2021;7(2):eP3010. doi: 10.22237/crp/1636070400
Included in
Behavioral Medicine Commons, Family Medicine Commons, Medical Neurobiology Commons, Medical Pharmacology Commons, Neurology Commons, Other Mental and Social Health Commons, Other Rehabilitation and Therapy Commons